← Back to headlines
Lilly's Once-Monthly Eczema Injectable Shows Durable Disease Control
Eli Lilly announced that its once-monthly injectable treatment for eczema delivered durable disease control in clinical trials, offering a potential new option for patients.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
